B9

General Information


DRACP ID  DRACP01185

Peptide Name   B9

Sequence  GNPCGESCVYLPCITTVVGCSCQNSVCYHN

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Hedyotis biflora

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
BxPC-3 Pancreatic ductal adenocarcinoma Carcinoma IC50=1.54 μM MTT assay 72h Patent
Capan-2 Pancreatic ductal adenocarcinoma Carcinoma IC50=1.32 μM MTT assay 72h Patent
MOH-1 Pancreatic adenocarcinoma Carcinoma IC50=1.14 μM MTT assay 72h Patent
PANC-1 Pancreatic ductal adenocarcinoma Carcinoma IC50=2.01 μM MTT assay 72h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01185

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C129H200N36O44S6

Absent amino acids  ADFKMRW

Common amino acids  C

Mass  366904

Pl  5.35

Basic residues  1

Acidic residues  1

Hydrophobic residues  6

Net charge  0

Boman Index  -1605

Hydrophobicity  28.67

Aliphatic Index  64.67

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  3355

Absorbance 280nm  115.69

Polar residues  19

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Novel cyclotides from Hedyotis biflora inhibit proliferation and migration of pancreatic cancer cell in vitro and in vivo

Doi 10.1007/s00044-013-0746-6

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.